Case report: Cancer-free survival after chemotherapy, targeted immunotherapy combination with proton therapy following space making technique in a patient with cholangiocarcinoma after choledochal cyst resection

Choledochal cysts (CCs) are rare cystic dilations of the intrahepatic and/or extrahepatic bile ducts. Malignancies arising during follow-up after excision of CCs have been reported in both children and adults, with no typical time frame for malignancy development. We present a case of a patient diag...

Full description

Saved in:
Bibliographic Details
Main Authors: Jian Kong, Qi Xia, Li Xu, Dongcun Jin, Wenbing Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1520248/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841555157839511552
author Jian Kong
Qi Xia
Li Xu
Dongcun Jin
Wenbing Sun
author_facet Jian Kong
Qi Xia
Li Xu
Dongcun Jin
Wenbing Sun
author_sort Jian Kong
collection DOAJ
description Choledochal cysts (CCs) are rare cystic dilations of the intrahepatic and/or extrahepatic bile ducts. Malignancies arising during follow-up after excision of CCs have been reported in both children and adults, with no typical time frame for malignancy development. We present a case of a patient diagnosed with CCs 36 years ago, who underwent resection and subsequently developed cancer. The patient received chemotherapy, targeted therapy, and immunotherapy, with efficacy evaluation indicating a state of stable disease. Considering tumor resistance after continuous systemic therapy and an unresectable tumor, proton therapy was selected for the next treatment. To prevent gastrointestinal side effects after proton therapy, the bile-enteric anastomosis was dismantled, and a greater omentum strip was used to fill the subhepatic space, creating a barrier between the biliary duct and the intestine. The patient successfully underwent proton therapy without any gastrointestinal complications. As CC-associated malignancy poses a lifelong risk even with complete resection, surveillance should be maintained throughout the follow-up period. Comprehensive treatment should be adopted to improve prognosis in malignancy after CC resection.
format Article
id doaj-art-443b4a49f9144ef09e5c04402c8c5015
institution Kabale University
issn 1664-3224
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-443b4a49f9144ef09e5c04402c8c50152025-01-08T06:11:46ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-01-011510.3389/fimmu.2024.15202481520248Case report: Cancer-free survival after chemotherapy, targeted immunotherapy combination with proton therapy following space making technique in a patient with cholangiocarcinoma after choledochal cyst resectionJian Kong0Qi Xia1Li Xu2Dongcun Jin3Wenbing Sun4Department of Hepatobiliary-Pancreatic-Splenic Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, ChinaDepartment of Hepatobiliary-Pancreatic-Splenic Surgery, Chaoyang Central Hospital, Chaoyang, Liaoning, ChinaDepartment of Hepatobiliary-Pancreatic-Splenic Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, ChinaProton Therapy Center, Tsuyama Chuo Hospital, Tsuyama, Okayama, JapanDepartment of Hepatobiliary-Pancreatic-Splenic Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, ChinaCholedochal cysts (CCs) are rare cystic dilations of the intrahepatic and/or extrahepatic bile ducts. Malignancies arising during follow-up after excision of CCs have been reported in both children and adults, with no typical time frame for malignancy development. We present a case of a patient diagnosed with CCs 36 years ago, who underwent resection and subsequently developed cancer. The patient received chemotherapy, targeted therapy, and immunotherapy, with efficacy evaluation indicating a state of stable disease. Considering tumor resistance after continuous systemic therapy and an unresectable tumor, proton therapy was selected for the next treatment. To prevent gastrointestinal side effects after proton therapy, the bile-enteric anastomosis was dismantled, and a greater omentum strip was used to fill the subhepatic space, creating a barrier between the biliary duct and the intestine. The patient successfully underwent proton therapy without any gastrointestinal complications. As CC-associated malignancy poses a lifelong risk even with complete resection, surveillance should be maintained throughout the follow-up period. Comprehensive treatment should be adopted to improve prognosis in malignancy after CC resection.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1520248/fullcholedochal cystcholangiocarcinomaspace makingproton therapyimmunotherapy
spellingShingle Jian Kong
Qi Xia
Li Xu
Dongcun Jin
Wenbing Sun
Case report: Cancer-free survival after chemotherapy, targeted immunotherapy combination with proton therapy following space making technique in a patient with cholangiocarcinoma after choledochal cyst resection
Frontiers in Immunology
choledochal cyst
cholangiocarcinoma
space making
proton therapy
immunotherapy
title Case report: Cancer-free survival after chemotherapy, targeted immunotherapy combination with proton therapy following space making technique in a patient with cholangiocarcinoma after choledochal cyst resection
title_full Case report: Cancer-free survival after chemotherapy, targeted immunotherapy combination with proton therapy following space making technique in a patient with cholangiocarcinoma after choledochal cyst resection
title_fullStr Case report: Cancer-free survival after chemotherapy, targeted immunotherapy combination with proton therapy following space making technique in a patient with cholangiocarcinoma after choledochal cyst resection
title_full_unstemmed Case report: Cancer-free survival after chemotherapy, targeted immunotherapy combination with proton therapy following space making technique in a patient with cholangiocarcinoma after choledochal cyst resection
title_short Case report: Cancer-free survival after chemotherapy, targeted immunotherapy combination with proton therapy following space making technique in a patient with cholangiocarcinoma after choledochal cyst resection
title_sort case report cancer free survival after chemotherapy targeted immunotherapy combination with proton therapy following space making technique in a patient with cholangiocarcinoma after choledochal cyst resection
topic choledochal cyst
cholangiocarcinoma
space making
proton therapy
immunotherapy
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1520248/full
work_keys_str_mv AT jiankong casereportcancerfreesurvivalafterchemotherapytargetedimmunotherapycombinationwithprotontherapyfollowingspacemakingtechniqueinapatientwithcholangiocarcinomaaftercholedochalcystresection
AT qixia casereportcancerfreesurvivalafterchemotherapytargetedimmunotherapycombinationwithprotontherapyfollowingspacemakingtechniqueinapatientwithcholangiocarcinomaaftercholedochalcystresection
AT lixu casereportcancerfreesurvivalafterchemotherapytargetedimmunotherapycombinationwithprotontherapyfollowingspacemakingtechniqueinapatientwithcholangiocarcinomaaftercholedochalcystresection
AT dongcunjin casereportcancerfreesurvivalafterchemotherapytargetedimmunotherapycombinationwithprotontherapyfollowingspacemakingtechniqueinapatientwithcholangiocarcinomaaftercholedochalcystresection
AT wenbingsun casereportcancerfreesurvivalafterchemotherapytargetedimmunotherapycombinationwithprotontherapyfollowingspacemakingtechniqueinapatientwithcholangiocarcinomaaftercholedochalcystresection